In Win For Generic Drug Maker, Panel Affirms: ANDA Doesn’t Infringe
WASHINGTON, D.C. —The Federal Circuit U.S. Court of Appeals on Aug. 18 left intact a Delaware federal judge’s determination that an abbreviated new drug application (ANDA) for generic Vasostrict would not...To view the full article, register now.
Already a subscriber? Click here to view full article